We are excited to announce our upcoming NUH Laboratory Medicine Symposium 2025, a landmark event showcasing the strengths of our collaboration with Mayo Clinic. This symposium with prestigious Mayo Clinic Speakers will highlight the transformative impact of our partnership in advancing laboratory diagnostics and healthcare in the region. Through expert discussions and groundbreaking insights, the event underscores our shared commitment to clinical excellence.
Focusing on updates in Haematology and Molecular Diagnostics, the symposium features distinguished speakers, including Dr Eric Hsi and Dr Sounak Gupta from Mayo Clinic, alongside NUH’s Haematologists, Dr Lee Shir Ying and Dr Tan Lip Kun.
Join us to celebrate the longstanding collaboration and explore how the synergy between NUH and Mayo Clinic addresses local and regional healthcare needs.
DR. ERIC HSI, MDDr. Eric Hsi is the Chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, Rochester. He is a renowned hematopathologist specializing in the diagnosis and classification of hematologic malignancies. His key research areas include:
He has coauthored over 350 peer reviewed manuscripts, numerous book chapters, the author of textbook Haematopathology, and served on multiple editorial boards.
Dr. Hsi is active in national organizations such as the College of American Pathologists, American Society for Clinical Pathology, American Society of Hematology, Lymphoma Research Foundation, and ALLIANCE and has served on committees for these organizations.
He has also served as Chair of the Department of Laboratory Medicine at Cleveland clinic and Atrium Health.
Sounak Gupta, attended Kasturba Medical College (India) and followed this with doctoral (Molecular Medicine, Penn State University) and post-doctoral training (Cancer Biology, Cleveland Clinic). He completed his residency in Anatomic and Clinical Pathology at Mayo Clinic and fellowship training at Memorial Sloan Kettering Cancer Center (Molecular and Genitourinary Pathology). He has a current appointment as an Associate Professor of Pathology and participates in the urologic and molecular pathology practice at Mayo Clinic.
He is involved with professional organizations such as the Genitourinary Pathology Society (GUPS) and has contributed to the World Health Organization (WHO) Classification of Tumors of the Urinary and Male Genital System. He currently serves as the Vice Chair for Research in the Division of Anatomic Pathology.
He also serves as the Vice Chair for the Oncology Practice within the Division of Laboratory Genetics and Genomics. In this role, he oversees ongoing clinical test development efforts that includes whole genome sequencing, and liquid biopsy-based minimal residual disease monitoring. His research interests include studying rare subtypes of kidney cancer and hereditary oncology
Dr. Lee Shir Ying graduated from the National University of Singapore Medical School in 2002, followed by training in internal medicine. In 2006, she earned her membership to the Royal College of Physicians of the United Kingdom. Dr. Lee subsequently completed her specialty training in haematology under the Joint Commission of Specialist Training Singapore and, in 2012, attained her fellowship with the Royal College of Pathologists of the United Kingdom.
Dr. Lee is a core faculty member of the national haematology training programme and serves as an Assistant Professor in the Department of Medicine at the Yong Loo Lin School of Medicine. Her clinical and research interests include:
Dr Tan Lip Kun graduated from Leicester Medical School, UK, in 1989. She was trained in both internal medicine and in Haematology. Dr. Tan has extensive experience in both laboratory and clinical haematology, with interests in:
Dr Tan was previously the Program Director for the NUHS Adult and Paediatric Haematopoietic Stem Cell Transplant Programme, a FACT-accredited centre. She is currently the Medical Director of the Processing Facility, Stem Cell Laboratory and Collection Facility, Apheresis Unit, NCIS. She is the Medical Director of the Blood Transfusion Services. She actively participates in both undergraduate teaching at Yong Loo Lin School of Medicine, NUS and postgraduate teaching in Haematology. Dr Tan is a member of the Clinical Ethics Committee and a member of the Blood Usage Committee at NUHS.
At the National level, Dr Tan held the position of the Protem Executive Director and was tasked to set up the Advanced Cell Therapy and Research Institute, Singapore (ACTRIS), a national cell and gene therapy program and GMP facility. She now sits as a member of the Clinical Services Strategy Committee for Cell Therapy. She is also a member of the Product Vigilance Advisory Committee of HSA.
Karolina Setyowati, Ph.D., is the Senior Product Specialist for the qPCR and Digital PCR portfolio at Thermo Fisher Scientific, focusing on understanding and prioritizing the needs of scientists and researchers to guide product development that truly supports their work.
Before joining the corporate world, Karol spent over a decade in translational research at the National University of Singapore, where she earned her Ph.D. in Biochemistry, followed by post-doctoral studies at the Genome Institute of Singapore. Throughout her academic career, she published over 15 scientific articles in high-impact peer-reviewed journals, exploring the roles of microRNAs in cardiovascular diseases and advancing genome editing for human-based discovery platforms and translational research.
Karol later transitioned into business development roles at leading biotech companies, gaining deep expertise in various technologies, applications, and market trends, with a strong emphasis on Digital PCR. This diverse background allows her to bridge the gap between research and product innovation, helping scientists advance their discoveries.
Lee Kee Wah is the regional Scientific Affairs Specialist for Digital Biology Group at the Bio-Rad Laboratories. Kee Wah graduated with a Ph.D from the National University of Singapore (Singapore), specializing in crosstalk between different sub-population of cancer cells.
He has also obtained his M.Sc and B.Sc Honors’ degrees from the University of Nottingham (UK) and University Malaya (Malaysia), respectively. Kee Wah started his career as a postdoctoral fellow at the Department of Anatomy, National University of Singapore, working mainly on cancer biomarker discovery and validation.
Day 2: 26 April 2025, Saturday (Updated as of 11 April 2025)
Haematology Workshop:
Lupus Anticoagulant Diagnostics and DOAC Impacts; Digital Morphology and Sysmex CBC-O
24 April 2025, Thursday, 9:00 AM to 12:30 PM
Number of Participants: 20
This workshop focuses on advanced laboratory diagnostics. It highlights innovative technologies and approaches. The workshop is conducted in collaboration with Sysmex Asia Pacific Pte Ltd. The program covers two main areas.
(I) Coagulation Confidence: Knows the Dos and Don’t
(II) Digital Morphology and Sysmex CBC-O: Haematology Beyond the Box
Molecular Oncology Workshop: Digital PCR Solutions for JAK2 V617F Mutation Detection Using Droplet Digital PCR and Microfluidic Array Partitioning Digital PCR
24 April 2025, Thursday, 1:30 PM to 5:00 PM
Number of Participants: 10
This workshop focuses on two advanced digital polymerase chain reaction-based (dPCR) solutions for detecting and quantifying the JAK2 V617F mutation. This somatic mutation in the Janus kinase 2 gene (JAK2) is commonly associated with myeloproliferative neoplasms (MPNs) such as polycythemia vera, essential thrombocythemia, and primary myelofibrosis. Accurate detection and quantification play a critical role in diagnosis, prognosis, and treatment monitoring. This workshop features a 30-minute theoretical introduction on the Bio-Rad's Droplet Digital PCR technology and the fully integrated Combinati Absolute Q Digital PCR using Microfluidic Array Partitioning (MAP) technology. This is followed by a 2.5-hour hands-on practical session, where the participants will set up the dPCR assays and analyse the run results on both platforms.
Molecular Microbiology Workshop: From Plate Cultures to Whole Genome Sequencing
24 April 2025, Thursday, 1:30 PM to 5:00 PM
Number of Participants: 10
This workshop offers a practical introduction to whole genome sequencing (WGS) for microbial identification and analysis. Participants will learn key steps, including DNA extraction using automated systems, quality control methods, and sequencing data analysis. The program includes hands-on training with commercial software (CLC Genomics Workbench) and open-source platforms (Galaxy, CGE Services). Through lectures and practical sessions, participants will explore the role of WGS in clinical microbiology, with applications such as antimicrobial resistance prediction and genome assembly. This workshop is designed for professionals seeking to expand their expertise in microbial genomics.
Supported By Qiagen
.png?sfvrsn=fec2eeb2_1){kind=logo}
